Target intelligence / Profile preview

CCL15-CCL14 readthrough (NMD candidate) (CCL15-CCL14)

Target
CCL15-CCL14
Molecular classification
non-coding RNA, long non-coding RNA (lncRNA)
01

Overview

CCL15-CCL14 readthrough is a naturally occurring non-coding RNA transcript formed by transcription read-through between the adjacent CCL15 and CCL14 genes located on human chromosome 17q11.2. Although the individual genes [CCL15 and CCL14] code for secreted chemokine proteins involved in immune cell recruitment, the readthrough transcript itself does not encode a protein and is thought to undergo nonsense-mediated decay. It is not known to function as a receptor, enzyme, transporter, or any other common drug target, nor is it relevant for chemokine signaling or pharmacology.[3] Important clarification: If your intention was to refer to either CCL15 or CCL14 protein, these are bona fide chemokine proteins; CCL15 is also called leukotactin-1 and CCL14 is a related CC chemokine. However, "CCL15-CCL14 readthrough" specifically refers to the bicistronic RNA species and not a functional protein or drug target[3][4][5].

Other names
CCL15-CCL14 readthroughchemokine (C-C motif) ligand 15-chemokine (C-C motif) ligand 14 readthroughENSG00000275688
02

Disease associations

Epidermolysis bullosa simplexBurkitt lymphoma

Beyond the preview

Go deeper on CCL15-CCL14 readthrough (NMD candidate) (CCL15-CCL14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCL15-CCL14 readthrough (NMD candidate) (CCL15-CCL14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call